Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment
Clinical trial NCT05628623 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05628623
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-23
- Primary completion
- 2026-02-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.